Latest Breaking News On - Rolling review - Page 3 : vimarsana.com

Rocket Pharmaceuticals Receives FDA Fast Track and Orphan Drug Designations for RP-A601 Gene Therapy for PKP2 Arrhythmogenic Cardiomyopathy (ACM)

Rocket Pharmaceuticals Receives FDA Fast Track and Orphan Drug Designations for RP-A601 Gene Therapy for PKP2 Arrhythmogenic Cardiomyopathy (ACM)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Kevin giordanoDrug administrationRocket pharmaceuticals incFast trackOrphan drugInvestigational new drugRolling reviewBiologic license applicationArrhythmogenic cardiomyopathyRocket pharmaceuticalsFanconi anemiaLeukocyte adhesion deficiency iPyruvate kinase deficiencyDanon diseasePrivate securities litigation reform actAnnual report

Rocket Pharmaceuticals (RCKT) Granted FDA Fast Track and Orphan Drug Designations for RP-A601

Rocket Pharmaceuticals (RCKT) Granted FDA Fast Track and Orphan Drug Designations for RP-A601
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Kevin giordanoRocket pharmaceuticals incDrug administrationRocket pharmaceuticalsFast trackOrphan drugInvestigational new drugRolling reviewBiologic license applicationArrhythmogenic cardiomyopathyFanconi anemiaLeukocyte adhesion deficiency iPyruvate kinase deficiencyDanon diseasePrivate securities litigation reform actAnnual report

Centessa Pharmaceuticals Receives Fast Track Designation

BOSTON and LONDON, May 22, 2023 (GLOBE NEWSWIRE) Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to.

United statesCity ofUnited kingdomKristenk sheppardExchange commissionCentessa pharmaceuticalsDrug administrationFast trackSaurabh sahaChief executive officerAccelerated approvalPriority reviewRolling reviewAnnual reportQuarterly reportsNasdaq cnta

Centessa Pharmaceuticals Receives Fast Track Designation from the U S FDA for SerpinPC for Hemophilia B

Centessa Pharmaceuticals Receives Fast Track Designation from the U S FDA for SerpinPC for Hemophilia B
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesCity ofUnited kingdomKristenk sheppardCentessa pharmaceuticalsExchange commissionCentessa pharmaceuticalscentessa pharmaceuticalsDrug administrationWall streetFast trackSaurabh sahaChief executive officerAccelerated approvalPriority reviewLooking statements thisRolling review

PharmaTher Holdings Submits Fast Track Application to FDA for KETARX™ (Ketamine) for the Treatment of Parkinson s Disease

TORONTO, May 02, 2023 PharmaTher Holdings Ltd. , a specialty pharmaceutical company, today announced the submission of a Fast Track Application to the U.S. Food and Drug Administration for. | May 2, 2023

Fabio chianelliPharmather holdings ltdRegulation services providerCompany or pharmatherNeither the canadian securities exchangeDrug administrationMother holdingsFast track applicationAccelerated approvalPriority reviewRolling reviewNew drug applicationTreating motor disordersLevodopa induced dyskinesiasFast trackCanadian securities exchange